Perrigo's Strategic Divestiture Prompts Buy Rating From Analyst Susan Anderson
TipRanksApr 26 08:07 ET
Sector Update: Health Care Stocks Decline Late Afternoon
Health care stocks retreated late Thursday afternoon, with the NYSE Health Care Index down 0.4% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.6%. The iShares Biotechnology ETF (IBB) dro
MT NewswiresApr 25 15:48 ET
Esteve Healthcare To Buy Perrigo's HRA Pharma Rare Diseases Business For Up To EUR 275 Mln
RTTNewsApr 25 06:35 ET
Perrigo: Consideration Includes EUR190M Cash Upfront, Up to EUR85M in Potential Earnouts >PRGO
Perrigo: Consideration Includes EUR190M Cash Upfront, Up to EUR85M in Potential Earnouts >PRGO
Dow JonesApr 25 06:06 ET
Perrigo Would Use Sale Proceeds for Debt Repayment >PRGO
Perrigo Would Use Sale Proceeds for Debt Repayment >PRGO
Dow JonesApr 25 06:06 ET
Perrigo: Proposed Divestiture Further Supports Strategic Focus on Consumer Self-Care >PRGO
Perrigo: Proposed Divestiture Further Supports Strategic Focus on Consumer Self-Care >PRGO
Dow JonesApr 25 06:05 ET
Express News | Perrigo Company PLC - Total Consideration Would Be Accretive to Perrigo's Current Enterprise Value-to-Ebitda Multiple
ReutersApr 25 06:00 ET
Express News | Perrigo Company PLC - Expected Impact From This Proposed Divestment Was Included in Company's Previously Issued 2024 Outlook
ReutersApr 25 06:00 ET
Express News | Perrigo Company PLC: Expected Net Proceeds to Be Redeployed for Debt Repayment
ReutersApr 25 06:00 ET
Express News | Perrigo Receives Binding Offer to Divest Its Hra Pharma Rare Diseases Business for up to €275 Million
ReutersApr 25 06:00 ET
99% Of This Perrigo Insider's Holdings Were Sold
From what we can see, insiders were net sellers in Perrigo Company plc's (NYSE:PRGO ) during the past 12 months. That is, insiders sold the stock in greater numbers than they purchased it.
Simply Wall StApr 24 10:57 ET
Express News | NYSE Order Imbalance 74103.0 Shares on Buy Side
Moomoo 24/7Apr 23 15:50 ET
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
DUBLIN, April 23, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2024 financial res
PR NewswireApr 23 08:09 ET
Express News | NYSE Order Imbalance 84204.0 Shares on Buy Side 84204.0 Shares on Buy Side
Moomoo 24/7Apr 19 15:50 ET
Express News | NYSE Order Imbalance 54060.0 Shares on Buy Side 54060.0 Shares on Buy Side
Moomoo 24/7Apr 18 15:50 ET
Express News | NYSE Order Imbalance 56226.0 Shares on Buy Side
Moomoo 24/7Apr 15 15:50 ET
Here's Why Perrigo Company PLC (PRGO) Stock Slumped in Q1
Yahoo FinanceApr 15 08:15 ET
Perrigo Is Maintained at Buy by Canaccord Genuity
Perrigo Is Maintained at Buy by Canaccord Genuity
Dow JonesApr 12 12:01 ET
Canaccord Genuity Maintains Buy on Perrigo, Maintains $42 Price Target
Canaccord Genuity analyst Susan Anderson maintains Perrigo with a Buy and maintains $42 price target.
Analyst UpgradesApr 12 11:50 ET
Opill and WNBA Team Up for Groundbreaking Partnership
--The Two Revolutionary Brands Will Redefine Contraception Accessibility-- GRAND RAPIDS, Mich. and NEW YORK, April 9, 2024 /PRNewswire/ -- Today, Perrigo Company plc, a leading provider of Consumer S
PR NewswireApr 9 12:30 ET
No Data
No Data